Inborn errors of immunity in Low German Mennonite communities in Mexico: a case series and narrative literature review - Summary - MDSpire

Inborn errors of immunity in Low German Mennonite communities in Mexico: a case series and narrative literature review

  • By

  • Luisa Berenise Gámez-González

  • Saúl Oswaldo Lugo-Reyes

  • Rogelio Guzmán-Cotaya

  • Sara Elva Espinosa-Padilla

  • Luis Enrique Murguía-Favela

  • Marco Antonio Yamazaki-Nakashimada

  • June 24, 2026

  • 0 min

Share

Objective:

To describe four clinical cases of inborn errors of immunity (IEI) in Low German Mennonite (LGM) patients in Mexico and contextualize these findings within a comprehensive literature review of previously reported IEI cases in this population.

Approach:
  • Study Design: A retrospective case series conducted at two tertiary pediatric referral centers in Mexico between 2020 and 2025.
  • Data Collection: Clinical, immunological, and genetic data were extracted from medical records, and genetic diagnoses were established using next-generation sequencing or whole-exome sequencing.
  • Literature Review: A narrative literature search was performed in PubMed, Embase, SciELO, and Web of Science to identify previously reported IEI cases in LGM populations.
Key Findings:
  • Four patients with distinct IEI were identified: one with G6PC3 deficiency, one with XLA due to a pathogenic variant in the BTK gene, and two with SCID.
  • All patients required disease-specific therapy, including granulocyte colony-stimulating factor, immunoglobulin replacement, and/or hematopoietic cell transplantation.
  • The literature review identified a broad spectrum of IEI in LGM populations, including cellular and humoral immunodeficiencies, phagocyte disorders, DNA repair defects, autoinflammatory conditions, and bone marrow failure syndromes.
Interpretation:

This exploratory case series contributes to the evidence on IEI in LGM populations.

Limitations:
  • Small sample size.
  • Retrospective design limits generalizability.
Conclusion:

Early diagnosis through newborn screening and accessible genetic testing remains essential to improve outcomes.

Original Source(s)

Related Content